E01_07 Prescribing: Hepatic/Renal Diseases Flashcards

1
Q

2017_Hepatic/Renal

Clearance of isoniazid is increased if:

A. Urine is alkaline
B. Urine is acidic
C. pH is not a factor

A

A. Urine is alkaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2017_Hepatic/Renal

In the presence of hepatic insufficiency, the loading dose of an IV administered and hepatically cleared drug needs to be:

A. Increased
B. Decreased
C. Same

A

C. Same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2017_Hepatic/Renal

In the presence of hepatic insufficiency, the loading dose of an orally administered and hepatically cleared drug needs to be:

A. Increased
B. Decreased
C. Same

A

B. Decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2017_Hepatic/Renal

In the presence of decreased protein binding, the maintenance dose of a high extraction ratio and hepatically cleared drug needs to be:

A. Increased
B. Decreased
C. Same

A

C. Same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2017_Hepatic/Renal

For a renal high extraction ratio drug, we expect a:

A. Higher bioavailability
B. Lower bioavailability
C. This extraction has no effect on bioavailability

A

C. This extraction has no effect on bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2017_Hepatic/Renal

Which two constitute the dual elimination pathway of phenytoin:

A

A. CYP2C9 and CYP2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2018_Hepatic/Renal

In liver disease, which isozyme is last to decrease?

A. 2D6
B. 3A4
C. 2C19
D. 2C9

A

A. CYP2D6

2C19 is the first to decline

2C19 -> 1A2 -> 3A -> 2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2018_Hepatic/Renal

If there are no studies done and the patient is Child Pugh class A (mild), how much of the dose will you give?

A. 75% maintenance dose
B. 50% maintenance dose
C. 25% maintenance dose

A

B. 50% maintenance dose

A – 50% of normal dose
B – 25%
C – use drugs with clinical safety data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2018_Hepatic/Renal

Warfarin is metabolized by CYP3A and then ketoconazole (a CYP3A inhibitor) was given. What is likely to happen?

A. Increased risk of bleeding
B. Decreased risk of bleeding
C. No effect

A

A. Increased risk of bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2018_Hepatic/Renal

If the protein binding of a drug is decreased, what happens to the loading dose?

a Increased
b Decreased
c No change

A

?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2016_Hepatic/Renal

True or False. In cirrhotic patients, BA of drugs with high extraction ratio is mor affected than low extraction ratio drugs.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2016_Hepatic/Renal

If with hepatic derrangement, only systemic clearance is affected.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2016_Hepatic/Renal

True or False. In patients with hepatic derangement, decrease in function of CYP3A is faster than CYP2D6.

A

True.

2D6 is last

How well did you know this?
1
Not at all
2
3
4
5
Perfectly